266 related articles for article (PubMed ID: 8072170)
1. [Genomic DNA fingerprinting of arbekacin-resistant MRSA by pulsed-field gel electrophoresis].
Nonoyama M; Ida T; Hasobe T; Shimauchi C; Inoue M; Okamoto R; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):627-33. PubMed ID: 8072170
[TBL] [Abstract][Full Text] [Related]
2. Pulse-field gel electrophoresis typing of methicillin-resistant Staphylococcus aureus strains susceptible to aminoglycosides isolated from 1993 to 2002.
Lescat M; Dupeyron C; Faubert E; Mangeney N
J Hosp Infect; 2004 Jul; 57(3):253-7. PubMed ID: 15236856
[TBL] [Abstract][Full Text] [Related]
3. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A
Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234
[TBL] [Abstract][Full Text] [Related]
4. Trends of arbekacin-resistant MRSA strains in Japanese hospitals (1979 to 2000).
Tsuchizaki N; Ishino K; Saito F; Ishikawa J; Nakajima M; Hotta K
J Antibiot (Tokyo); 2006 Apr; 59(4):229-33. PubMed ID: 16830890
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial activity of arbekacin, a new aminoglycoside antibiotic, against methicillin-resistant Staphylococcus aureus.
Inoue M; Nonoyama M; Okamoto R; Ida T
Drugs Exp Clin Res; 1994; 20(6):233-9. PubMed ID: 7758395
[TBL] [Abstract][Full Text] [Related]
6. [Genomic DNA fingerprinting by pulsed-field gel electrophoresis for study of nosocomial infection caused by methicillin-resistant Staphylococcus aureus].
Ichiyama S
Nihon Rinsho; 1992 May; 50(5):992-7. PubMed ID: 1507456
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
8. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus].
Deguchi K; Suzuki Y; Ishihara R; Ishii Y; Nakazawa A; Matsumoto Y; Nishinari C; Nakane Y; Fukumoto T
Jpn J Antibiot; 1997 Jan; 50(1):1-11. PubMed ID: 9059909
[TBL] [Abstract][Full Text] [Related]
9. Investigation of nosocomial infection caused by arbekacin-resistant, methicillin-resistant Staphylococcus aureus.
Obayashi Y; Fujita J; Ichiyama S; Hojo S; Negayama K; Takashima C; Miyawaki H; Tanabe T; Yamaji Y; Kawanishi K; Takahara J
Diagn Microbiol Infect Dis; 1997 Jun; 28(2):53-9. PubMed ID: 9239494
[TBL] [Abstract][Full Text] [Related]
10. [Emergence of arbekacin resistant strains among methicillin-resistant Staphylococcus aureus].
Suzuki T; Fujita K; Nagamachi Y; Okubo T
Jpn J Antibiot; 1994 Jun; 47(6):634-9. PubMed ID: 8072171
[TBL] [Abstract][Full Text] [Related]
11. [Antibacterial activities of arbekacin against recently isolated methicillin-resistant Staphylococcus aureus (I)].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Suzuki K; Fukayama S; Ishihara R
Jpn J Antibiot; 1993 Mar; 46(3):234-41. PubMed ID: 8510320
[TBL] [Abstract][Full Text] [Related]
12. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
13. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
14. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. III. Combined effects of arbekacin with cefotiam or cefuzonam].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Oct; 45(10):1305-11. PubMed ID: 1479682
[TBL] [Abstract][Full Text] [Related]
15. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
[TBL] [Abstract][Full Text] [Related]
16. DNA typing of methicillin-resistant Staphylococcus aureus: isolates and factors associated with nosocomial acquisition in two Brazilian university hospitals.
Santos KRN; Teixeira LM; Leal GS; Fonseca LS; Gontijo Filho PP
J Med Microbiol; 1999 Jan; 48(1):17-23. PubMed ID: 9920121
[TBL] [Abstract][Full Text] [Related]
17. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
Kondo S
Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
[TBL] [Abstract][Full Text] [Related]
18. Genomic DNA fingerprinting by pulsed-field gel electrophoresis as an epidemiological marker for study of nosocomial infections caused by methicillin-resistant Staphylococcus aureus.
Ichiyama S; Ohta M; Shimokata K; Kato N; Takeuchi J
J Clin Microbiol; 1991 Dec; 29(12):2690-5. PubMed ID: 1757534
[TBL] [Abstract][Full Text] [Related]
19. Nosocomial spread of meticillin-resistant Staphylococcus aureus with β-lactam-inducible arbekacin resistance.
Harada Y; Chong Y; Shimono N; Miyake N; Uchida Y; Kadowaki M; Akashi K; Shimoda S
J Med Microbiol; 2014 May; 63(Pt 5):710-714. PubMed ID: 24493159
[TBL] [Abstract][Full Text] [Related]
20. [Combined effects of arbekacin with other antibiotics against methicillin-resistant Staphylococcus aureus. II. The combined effect of arbekacin with imipenem or cefminox].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1992 Aug; 45(8):958-64. PubMed ID: 1433902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
